Celcuity stock soars after hours on breakthrough therapy designation for cancer drug
admin Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S.…
Read MoreBiopharmaceuticals
Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreThis strategist warned investors not to chase momentum at the top. Now he says it’s time to be a contrarian.
Michael Darda, chief economist and market strategist at MKM Partners, was no fan of the…
Read MoreMerck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read More
Caesars, SeaWorld downgraded on ‘waning’ confidence in ability to withstand looming recession
Shares of Caesars Entertainment Inc. and SeaWorld Entertainment Inc. slumped Wednesday after downgrades from KeyBanc…
Read More